At presentation | During lifetime | |
---|---|---|
(A) Diagnosis | Primary diagnosis | Primary diagnosis |
Probable CBD | 9 | 12 |
Possible CBD | 9 (18 including ‘Probable CBD’) | 1 (13 including ‘Probable CBD’) |
Probable CBS | 3 | 4 |
Possible CBS | 4 (7) | 6 (10) |
Frontal behavioural-spatial (FBS) | 0 (12) | 2 (13) |
FBS–NAV overlap | 0 | 1 |
Non-fluent/agrammatic variant (NAV) | 0 (11) | 3 (12) |
PSP phenotype | 1 (1) | 0 (6) |
(B) Diagnosis | At presentation | During lifetime |
---|---|---|
CBD | 10 | 13 |
PNFA | 2 | 2 |
FTD | 4 | 4 |
PSP | 1 | 0 |
Other | 2 (1 AD, 1 IPD) | 0 |
AD, Alzheimer's disease; CBD, corticobasal degeneration; FTD, frontotemporal dementia; IPD, idiopathic Parkinson's disease; PNFA, progressive non-fluent aphasia; PSP, progressive supranuclear palsy; PSPS, progressive supranuclear palsy syndrome.